Innovations in blood pressure measurement and reporting technology: International Society of Hypertension position paper endorsed by the World Hypertension League, European Society of Hypertension, Asian Pacific Society of Hypertension, and Latin Ame

Blood pressure (BP) is a key contributor to the lifetime risk of preclinical organ damage and cardiovascular disease. Traditional clinic-based BP readings are typically measured infrequently and under standardized/resting conditions and therefore do not capture BP values during normal everyday activity. Therefore, current hypertension guidelines emphasize the importance of incorporating out-of-office BP measurement into strategies for hypertension diagnosis and management. However, conventional home and ambulatory BP monitoring devices use the upper-arm cuff oscillometric method and only provide intermittent BP readings under static conditions or in a limited number of situations. New innovations include technologies for BP estimation based on processing of sensor signals supported by artificial intelligence tools, technologies for remote monitoring, reporting and storage of BP data, and technologies for BP data interpretation and patient interaction designed to improve hypertension management ("digital therapeutics"). The number and volume of data relating to new devices/technologies is increasing rapidly and will continue to grow. This International Society of Hypertension position paper describes the new devices/technologies, presents evidence relating to new BP measurement techniques and related indices, highlights standard for the validation of new devices/technologies, discusses the reliability and utility of novel BP monitoring devices, the association of these metrics with clinical outcomes, and the use of digital therapeutics. It also highlights the challenges and evidence gaps that need to be overcome before these new technologies can be considered as a user-friendly and accurate source of novel BP data to inform clinical hypertension management strategies.

Authors

Institutions

Publication Details

Journal
Journal of Hypertension
Published
2024-09-09
DOI
https://doi.org/10.1097/hjh.0000000000003827
Citations
29
Primary Topic
Blood Pressure and Hypertension Studies
Type
article
Field-Weighted Citation Impact
11.66
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Innovations in blood pressure measurement and reporting technology: International Society of Hypertension position paper endorsed by the World Hypertension League, European Society of Hypertension, Asian Pacific Society of Hypertension, and Latin Ame

Isabella Tan, Buna Bhandari, Tomas L. Bothe, Keneilwe N. Mmopi et al.
29 citations
Journal of Hypertension
Blood Pressure and Hypertension Studies
11.66
article

Innovations in blood pressure measurement and reporting technology: International Society of Hypertension position paper endorsed by the World Hypertension League, European Society of Hypertension, Asian Pacific Society of Hypertension, and Latin Ame

Isabella Tan, Buna Bhandari, Tomas L. Bothe, Keneilwe N. Mmopi, Bryan Williams, George S. Stergiou, Maciej Tomaszewski, Nadia Khan, Michihiro Satoh, José López-López, Jesús López-Rivera, Fadi J. Charchar, Aletta Elisabeth Schutte, Elisabetta Bianchini, Peter Charlton, Alberto Avolio, Dean S. Picone, Naoko Tomitani, Richard J. McManus, Kazuomi Kario, Daichi Shimbo, Ji‐Guang Wang
article en
29 citations

Abstract

Blood pressure (BP) is a key contributor to the lifetime risk of preclinical organ damage and cardiovascular disease. Traditional clinic-based BP readings are typically measured infrequently and under standardized/resting conditions and therefore do not capture BP values during normal everyday activity. Therefore, current hypertension guidelines emphasize the importance of incorporating out-of-office BP measurement into strategies for hypertension diagnosis and management. However, conventional home and ambulatory BP monitoring devices use the upper-arm cuff oscillometric method and only provide intermittent BP readings under static conditions or in a limited number of situations. New innovations include technologies for BP estimation based on processing of sensor signals supported by artificial intelligence tools, technologies for remote monitoring, reporting and storage of BP data, and technologies for BP data interpretation and patient interaction designed to improve hypertension management ("digital therapeutics"). The number and volume of data relating to new devices/technologies is increasing rapidly and will continue to grow. This International Society of Hypertension position paper describes the new devices/technologies, presents evidence relating to new BP measurement techniques and related indices, highlights standard for the validation of new devices/technologies, discusses the reliability and utility of novel BP monitoring devices, the association of these metrics with clinical outcomes, and the use of digital therapeutics. It also highlights the challenges and evidence gaps that need to be overcome before these new technologies can be considered as a user-friendly and accurate source of novel BP data to inform clinical hypertension management strategies.

Journal of HypertensionVol. 42(11)
The University of Sydney (AU), University of Tasmania (AU), University of British Columbia (CA), Jichi Medical University (JP), Federation University (AU), University of Leicester (GB), University of Botswana (BW), The University of Melbourne (AU), National and Kapodistrian University of Athens (GR), University of Cambridge (GB), Columbia University Irving Medical Center (US), Manchester Academic Health Science Centre (GB), Ruijin Hospital (CN), Manchester Royal Infirmary (GB), University of Manchester (GB), UNSW Sydney (AU), National Institute for Health and Care Research (GB), University of Oxford (GB), Manchester University NHS Foundation Trust (GB), Istituto di Fisiologia Clinica (IT), The George Institute for Global Health (AU), Shanghai Institute of Hypertension (CN), Universidad De Santander (CO), National Research Council (IT), Harvard Global Health Institute (US), Sotiria General Hospital (GR), University College London (GB), Charité - Universitätsmedizin Berlin (DE), Tohoku Medical and Pharmaceutical University (JP), Macquarie University (AU)
Openalex Percentile: Top 1%
Blood Pressure and Hypertension Studies
11.66
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.